ketamine + bupivacaine + dexmedetomidine

This is a combination of three drugs—ketamine, bupivacaine, and dexmedetomidine—used primarily as an adjuvant regimen for regional anesthesia and postoperative analgesia. - **Ketamine** is a dissociative anesthetic that acts mainly as an antagonist at the N-methyl-D-aspartate (NMDA) receptor, providing analgesic and anesthetic effects. - **Bupivacaine** is a long-acting local anesthetic that blocks voltage-gated sodium channels in neuronal membranes, inhibiting nerve impulse transmission to provide regional anesthesia. - **Dexmedetomidine** is a highly selective alpha-2 adrenergic receptor agonist with sedative, anxiolytic, and analgesic properties; it reduces sympathetic tone and opioid requirements without causing significant respiratory depression. When used together (often in neuraxial or local infiltration techniques), this combination has been shown to prolong the duration of sensory and motor blockades, enhance postoperative pain control, reduce opioid consumption after surgery, improve hemodynamic stability during procedures, and minimize adverse effects associated with each drug when used alone[1][2][3][4]. The combination leverages complementary mechanisms for superior sedation/analgesia while mitigating individual side effects.

Other names

ketamine + bupivacine + dexmedetomidineKetamine, bupivacaine, and dexmedetomidine combination